{"slug":"clinicalintelpulse-6f9d7300","name":"ClinicalIntelPulse","summary":"FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results, approval-probability scores and historical phase-3 success rates. Worldwide. For biotech-investing and payer agents.","status":"live","indexable":true,"listed_since":"2026-10-25T17:51:03.183439Z","sources":[{"source":"x402_bazaar","external_id":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook","owner_address":"0x50ab2018c06c6e4eaa9ba52057eb55ed284912fc","seen_at":"2026-10-26T05:59:27.172219Z","removed_at":null}],"endpoints":[{"url":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook","host":"clinicalintelpulse.theaslangroupllc.com","protocol":"x402","state":"live","last_probe_at":"2026-10-25T23:00:54.140093Z","last_ok_at":"2026-10-25T23:00:54.140093Z","tools_count":null,"tools_changed_at":null,"uptime_24h":1.0,"uptime_30d":1.0}],"also_listed_as":[{"slug":"clinicalintelpulse-theaslangroupllc-com-ec82c81d","name":"clinicalintelpulse.theaslangroupllc.com"}],"payment_options":[],"usage":{"source":"x402_bazaar","unique_payers_30d":1,"paid_calls_30d":1,"last_paid_at":"2026-10-16T02:44:09.474Z","reported_at":"2026-10-26T05:59:27.172219Z"},"notice":"Not affiliated with addrbook — claim or request removal."}